ofloxacin has been researched along with 4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedoui, A; Chekir-Ghedira, L; Cheraif, I; Dhaouifi, Z; Ghedira, K; Kalboussi, Z; Lahmar, A; Mokdad-Bzeouich, I | 1 |
1 other study(ies) available for ofloxacin and 4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol
| Article | Year |
|---|---|
Reversal of resistance in bacteria underlies synergistic effect of essential oils with conventional antibiotics.
Topics: Acinetobacter baumannii; Amoxicillin; Animals; Anti-Infective Agents; Bacteria; beta-Lactamases; Bicyclic Monoterpenes; Cell Line; Cell Proliferation; Cell Survival; Cyclohexenes; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Escherichia coli; Gas Chromatography-Mass Spectrometry; Humans; Keratinocytes; Limonene; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Monoterpenes; Novobiocin; Ofloxacin; Oils, Volatile; Oxacillin; Piperacillin; Plant Extracts; Plant Oils; Sesquiterpenes, Eudesmane; Spleen; Terpenes; Tetracycline; Time Factors | 2017 |